small-molecule discovery

Suppliers: 1
States & provinces: 1
Countries: 1

1 small-molecule discovery supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

CuraGenAI designs disease-modifying small molecules for hard-to-treat diseases and accelerates target-to-lead discovery by combining generative AI, reinforcement learning, and ML model architectures with biology and structure-based validation. Its CureRX platform delivers synthesis-ready lead series to pharma and biotech partners, compressing target-to-lead discovery from years to weeks. Selected programs advance toward clinical translation through CuraGen Neuro Therapeutics, including a brain-directed ACAT1/SOAT1 program in glioblastoma.

ADMET predictionde novo molecular designgenerative chemistrymulti-objective optimizationReinforcement learningstructure-based validationtarget definition and druggability assessment

Related capabilities

Other processes offered by the shops that list small-molecule discovery.

ADMET prediction (1)
de novo molecular design (1)
generative chemistry (1)
multi-objective optimization (1)
Reinforcement learning (1)
structure-based validation (1)
target definition and druggability assessment (1)

Browse all capabilities

small-molecule discovery

Suppliers

CURAGEN AI LABS

Related capabilities